InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.17
(
0.05%
)
Bitcoin
64,174.21
(
0.27%
)
Post# of 27761
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

vlispxpert

Send PM Follow Ignore
Followers 249
Posts 28299
Boards Moderated 2
Alias Born 08/21/2003

vlispxpert

Member Level

Re: None

Friday, 11/17/2017 11:56:17 AM

Friday, November 17, 2017 11:56:17 AM

Post# of 27761
E G L T may be big one:

November 16, 2017
7:50 pm ET
Egalet Announces Positive Top-Line Results from Phase 3 Safety Study Evaluating Safety of Egalet-002

In addition, a phase 3 trial evaluating the safety and efficacy of Egalet-002 in patients with moderate-to-severe chronic pain is expected to be completed by year end.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up